BioStone will develop a DIVA ELISA to support vaccine evaluation and disease surveillance. Dallas–Fort Worth, TX — October 15, 2026 — BioStone Animal Health LLC is pleased to announce its participation in Duo-ProTectz, a three-year international research project led by The Pirbright Institute in the United Kingdom. The project aims to develop a bivalent vaccine…
Dallas–Fort Worth, TX – October 8, 2026 – BioStone Animal Health LLC proudly announces the launch of the AsurDx™ Anaplasmosis Antibody Test Kit, a rapid and sensitive indirect ELISA designed to detect antibodies against Anaplasma bacteria in bovine serum and plasma samples. Bovine anaplasmosis, primarily caused by Anaplasma marginale, is an infectious disease affecting cattle…
BioStone presented its AsurBreed™ Early Open Cow Test and connected with veterinarians, researchers, and artificial insemination professionals from the U.S. and overseas. MADISON, WISCONSIN — September 18, 2026 — BioStone Animal Health was pleased to exhibit at the 30th Annual National Association of Animal Breeders (NAAB) Conference in Madison, Wisconsin. During the conference, the BioStone…
Visit BioStone at Booth #530 to learn about autogenous bacterin services and emerging cattle reproductive management technologies. DALLAS-FORT WORTH, TX — August 25, 2026 — BioStone Animal Health is pleased to announce that it will exhibit at the 2026 American Association of Bovine Practitioners (AABP) Annual Conference, taking place August 27–29 in Minneapolis, Minnesota. Attendees…
BioStone Offers Autogenous Bacterin Vaccine Programs for Cattle Pink Eye USDA-regulated manufacturing in the Dallas–Fort Worth area supports custom autogenous bacterins and inactivated bacterial antigens for U.S. cattle operations facing Moraxella-associated pinkeye challenges DALLAS-FORT WORTH, TX — August 14, 2026 — Infectious bovine keratoconjunctivitis (IBK), commonly known as cattle pinkeye, is one of the most…
BioStone Animal Health Connects with the Cattle Industry at the 2026 Texas A&M Beef Cattle Short Course BioStone highlights autogenous bacterin services and the AsurBreed™ Early Open Cow Test while connecting with cattle producers, veterinarians, and industry professionals DALLAS-FORT WORTH, TX — August 6, 2026 — BioStone Animal Health recently exhibited at Texas A&M’s Beef…
Cervical-swab ELISA is being developed to help identify open cattle as early as Days 16–18 after insemination SOUTHLAKE, Texas — July 29, 2026 — BioStone Animal Health will preview the AsurBreed™ Early Open Cow Test, or OCT, at several cattle and veterinary industry events this summer ahead of a planned Fall 2026 commercial launch. BioStone…
DALLAS-FORT WORTH, TX — June 26, 2026 — BioStone Scientific has launched two new AsurPure™ enzymatic assay kits for metabolic biomarker testing in bovine serum: the AsurPure™ β-Hydroxybutyrate (BHBA) Enzymatic Assay Kit and the AsurPure™ Non-Esterified Fatty Acids (NEFA) Enzymatic Assay Kit. These laboratory-based tools are designed to support quantitative measurement of key metabolic biomarkers…
Dallas – Forth Worth, TX — May 21, 2026 — BioStone Animal Health LLC proudly announces the launch of the AsurDx™ Hantavirus (HTNV) Real-Time RT-PCR Detection Kit (HTNV 2050-RT), a highly sensitive molecular diagnostic assay designed for the rapid detection of Hantavirus RNA in clinical and research samples. The AsurDx™ Hantavirus PCR kit utilizes advanced one-step fluorescent real-time…
Dallas – Forth Worth, TX — May 12, 2026 — BioStone Animal Health is pleased to announce that the AsurDx™ African Swine Fever Virus (ASFV) Antibody Indirect ELISA (iELISA) has been independently evaluated by the Friedrich-Loeffler-Institut (FLI), Germany’s National Reference Laboratory for African Swine Fever (ASF), with the study results published in the peer-reviewed scientific journal Pathogens. The…